These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

104 related items for PubMed ID: 6394185

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. [Hypermineralcorticism syndrome secondary to topical application of 9-alpha-fluoroprednisolone (author's transl)].
    Vasconez F, Pérez-Garcia R, Olivas E, Bolívar JE, Valderrábano F.
    Med Clin (Barc); 1980 Dec 15; 75(10):430-4. PubMed ID: 7464329
    [Abstract] [Full Text] [Related]

  • 3. Pseudoprimary hyperaldosteronism from topical application of 9-alpha-fluorprednisolone on the skin.
    Brognoli M, Doregatti C, Roncali M, Orlandini G.
    Clin Nephrol; 1985 Dec 15; 24(6):315-6. PubMed ID: 4075602
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. [Excess mineralocorticoid syndrome secondary to nasal sprays containing 9 alpha-fluoroprednisolone].
    Foresti V, Parisio E, Ricci G.
    Minerva Med; 1987 Sep 15; 78(17):1305-11. PubMed ID: 2444906
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Factitious hypertension with mineralocorticoid excess in an infant.
    De Stefano P, Bongo IG, Borgna-Pignatti C, Severi F.
    Helv Paediatr Acta; 1983 May 15; 38(2):185-9. PubMed ID: 6874387
    [Abstract] [Full Text] [Related]

  • 9. [Hypertension and hypokalemia caused by a nasal spray containing fluorprednisolone acetate].
    Maiorano G, Loiacono N, Di Bello V, Contursi V, Castelnuovo F, Albano O.
    Boll Soc Ital Cardiol; 1981 May 15; 26(5):465-71. PubMed ID: 7340877
    [No Abstract] [Full Text] [Related]

  • 10. Primary aldosteronism: renaissance of a syndrome.
    Young WF.
    Clin Endocrinol (Oxf); 2007 May 15; 66(5):607-18. PubMed ID: 17492946
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. 'Essential' hypertension with hypokalemia. Caused by aldosterone-secreting adrenal adenoma.
    Burke M, Papo J, Stavorovsky M, Almog C.
    Postgrad Med; 1984 Aug 15; 76(2):173, 176-8. PubMed ID: 6462970
    [Abstract] [Full Text] [Related]

  • 14. A case of primary aldosteronism due to unilateral adrenal hyperplasia.
    Katayama Y, Takata N, Tamura T, Yamamoto A, Hirata F, Yasuda H, Matsukuma S, Daido Y, Sasano H.
    Hypertens Res; 2005 Apr 15; 28(4):379-84. PubMed ID: 16138569
    [Abstract] [Full Text] [Related]

  • 15. [Arterial hypertension secondary to the application of 9-alpha-fluoroprednisolone ointments].
    Arnal JM, Moneo MI, Loris C.
    An Esp Pediatr; 1987 Jan 15; 26(1):65-6. PubMed ID: 3826948
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. [Primary aldosteronism presented with intracranial hemorrhage].
    Nakagawa A, Su CC, Saito K, Yamashita Y, Shirane R, Yoshimoto T.
    No Shinkei Geka; 2001 Oct 15; 29(10):973-7. PubMed ID: 11681014
    [Abstract] [Full Text] [Related]

  • 19. The diagnosis of primary aldosteronism and separation of two major subtypes.
    Weinberger MH, Fineberg NS.
    Arch Intern Med; 1993 Sep 27; 153(18):2125-9. PubMed ID: 8379804
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.